Apol1-associated Kidney Disease
📧 Sign up to get email alerts when something new happens for Apol1-associated Kidney Disease.
Sign up free-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease [Phase 2]
Phase 2 trial investigating a JAK-STAT pathway inhibitor for APOL1-associated kidney disease has completed (sponsor: Duke University).
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: APOL1 Genetic Testing in African Americans
This clinical trial update from St. Louis University describes evaluating APOL1 genetic testing in African Americans to understand genetic p…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: APOL1 Genotyping CTA Clinical Performance Study [NA]
Status update for a clinical trial evaluating APOL1 genotyping in APOL1-associated kidney disease; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1
Clinical trial update investigating predictive determinants of nephrotic syndrome remission in patients with at-risk APOL1 polymorphisms, in…